• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assay Kits
      • Transcreener® ADP² Kinase Assay Kits
        • Transcreener® ADP2 Assay Kit – FP Readout
        • Transcreener® ADP2 Assay Kit – FI Readout
        • Transcreener® ADP2 Assay Kit – TR-FRET Readout
      • Transcreener® ADO CD73 Assay Kit
      • Transcreener® ADPR Assay Kit
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay Kits
        • Transcreener® AMP2/GMP2 FP Assay
        • Transcreener® AMP2/GMP2 Assay Kit – TR-FRET Readout
      • Transcreener® cGAMP cGAS Assay Kits
        • Transcreener® cGAMP Assay Kit – FP Readout
        • Transcreener® cGAMP Assay Kit – TR-FRET Readout
      • Transcreener dAMP Exonuclease Assay Kit
      • Transcreener® EPIGEN SAH Methyltransferase Assay Kit
      • Transcreener® GDP GTPase Assay Kits
        • Transcreener® GDP Assay Kit – FP Readout
        • Transcreener® GDP Assay Kit – FI Readout
        • Transcreener® GDP Assay Kit – TR-FRET Readout
      • Transcreener® UDP² Glycosyltransferase Assay Kits
        • Transcreener® UDP2 Assay Kit – FP Readout
        • Transcreener® UDP2 Assay Kit – FI Readout
        • Transcreener® UDP2 Assay Kit – TR-FRET Readout
      • Transcreener® 2-5A OAS Assay Kit
    • AptaFluor® HTS Assay Kits
      • AptaFluor® SAH Methyltransferase Assay Kit
    • Enzyme Assay Systems
      • CD38 Assay System
      • TREX1 Assay System
    • Recombinant Enzymes
      • Human CD38 Enzyme
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
      • Human TREX1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • GTPase Profiling Services
    • ATPase Profiling Services
  • Assays by Target
    • Kinase Assays
      • ADK Assays – Application
      • AMPK Assays – Application
      • IKK-beta Assays – Application
      • IRAK4 Assays – Application
      • JAK1 Assays – Application
      • JAK3 Assays – Application
      • MAPK8 Assays – Application
      • PKR Assays – Application
      • RIPK1 Assays – Application
      • RIPK2 Assays – Application
      • TBK1 Assays – Application
    • GTPase Assays
      • GAP Assays – Application
      • GEF Assays – Application
      • KRAS Assays – Application
      • HRAS Assays – Application
      • NRAS Assays – Application
      • RRAS Assays – Application
      • Rac1 Assays – Application
      • RhoA Assays – Application
      • RhoC Assays – Application
      • Cdc42 Assays – Application
      • Ran Assays – Application
    • Methyltransferase Assays
      • EZH2 Assays – Application
      • G9a Assays – Application
      • SET7/9 Assays – Application
      • SET8 Assays – Application
      • PRMT1 Assays – Application
      • PRMT3 Assays – Application
      • PRMT4 Assays – Application
    • STING Pathway Assays
      • cGAS Assay Kits
      • ENPP1 Assays – Application
      • TREX1 Assay System
      • IKK-beta Assays – Application
      • TBK1 Assays – Application
    • Nucleotidase Assays
      • CD38 Assay System
      • CD39 Assays – Application
      • CD73 Activity Assay Kits
    • Helicase / ATPase Assays
      • DDX3 Assays – Application
      • NSP13 Assays – Application
      • p97 Assays – Application
      • Ketohexokinase Assays – Application
    • Glycosyltransferase Assays
      • Toxin B Assays – Application
      • GALNT2 Assays – Application
      • GALNT3 Assays – Application
      • BGalT1 Assays – Application
    • Phosphodiesterase Assays
      • PDE3 Assays – Application
      • PDE4 Assays – Application
      • PDE5 Assays – Application
      • PDE7 Assays – Application
    • Ligase and Synthetase Assays
      • SUMO E1 Assays – Application
      • Acetyl CoA Synthetase Assays – Application
    • Exonuclease Assays
      • TREX1 Assay System
      • WRN Exonuclease Assays – Application
    • OAS Assays
      • OAS1 Assay Kits
    • Other Enzyme Assays
      • NUDT5 Assays – Application
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

SIRT2 Isoforms in Neurodegenerative Diseases & Cancer

by Bellbrook Labs / Tuesday, 29 November 2022 / Published in Emerging Targets, HTS Assays, Innate Immunity, Neurodegenerative Diseases
SIRT2 Affects Neurodegenerative Diseases

Silent information regulator type 2 (Sirtuin 2 or SIRT2) is a highly evolutionarily conserved NAD+ dependent deacetylase. SIRT2 is the only Sirtuin that acts in the cytosol. It expresses in almost all tissues, but most abundantly in the central nervous system. While SIRT2 is classified as a type III histone deacetylase, it is also capable of performing this function on non-histone acetyllysine-bearing substrates. In addition, SIRT2 is capable of ADP-ribosylation, demyristoylase activity, and long-chain fatty acid deacylation.1

Structure & Function

The structure of SIRT2 consists of an N-terminal nuclear export sequence, a catalytic core, and a C-terminal nuclear import sequence. The catalytic core comprises a larger NAD+ binding Rossman fold domain hinged to a smaller zinc-binding domain. Together, these features create a large groove capable of interacting with NAD+ (Rossman domain) and negotiating protein-protein interactions between SIRT2 and its substrates (zinc-binding domain).2

Given its intracellular mobility, catalytic properties, and protein interactivity, SIRT2 has been found to participate in diverse cellular functions: DNA replication, transcription, & translation; epigenetic & post-translational modifications; genome integrity; autophagy; mitosis; lipid metabolism signaling; glucose metabolism signaling; inflammation; oxidative stress; cardiac & hepatic protection; and, most controversially, neurodegenerative diseases & cancer.3

Over the years, conflicting evidence both implicates and exonerates SIRT2 in neurological disorders and cancer. There are arguments for protective, coincidental, and causative aspects of SIRT2 in these disorders.4 Why should this be, and what could possibly disentangle these conflicting lines of evidence?

Isoforms of SIRT2

Currently, scientists identify 3 distinct SIRT2 isoforms. Isoforms 1 and 2 are fully functional deacetylases that can shuttle between the cytoplasm and the nucleus. Isoform 1, at 43 kDa, is expressed from all 16 exons of the SIRT2 gene and is predominantly found in skeletal muscle cytoplasm. Isoform 2, at 39 kDa, lacks expressed sequences from exons 1 through 3, predominantly exists in the fully mature central nervous system, and distributes across both the nucleus and cytoplasm. The missing first 37 amino acids of the full-length SIRT2 impair its ability to associate with chromatin.

Isoform 5 (murine isoform 3), at 36kDa, skips exons 2 through 4 and increasingly accumulates in aging central nervous tissue. Due to the omission of N-terminal amino acids 6 through 76, this splice variant lacks a functional nuclear export sequence (amino acids 41-51) and canonical catalytic capabilities, remaining confined to the nucleus.5 Isoform 5 does seem to confer epigenetic resistance to HBV infection.6

Looking Ahead

Could the key to resolving the conflicting roles of SIRT2 in disease depend upon which isoform is predominantly involved in a given disease state? Is it possible to reverse these diseases by silencing the prevailing isoform and inducing one that appropriately expresses in healthy tissue? Given the differing localizing and functional properties of the known isoforms, the particular SIRT2 splice variant present may be more important than the total amount of SIRT2 in a given tissue.

 

References

  1. Liu, Y. et al. (2020) Emerging Role of Sirtuin 2 in Parkinson’s Disease. Front. Aging Neurosci., 11:372, 1-11. Review. https://doi.org/10.3389/fnagi.2019.00372
  2. Zhang, F. and Li, B. (2022) Will Sirtuin 2 Be a Promising Target for Neuroinflammatory disorders? Front. Cell Neurosci., 16:915587, 1-13. Review. https://doi.org/10.3389/fncel.2022.915587
  3. Zhu, C. et al (2022) Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction. Hindawi Genetics Research, 2022:9282484, 1-14. Review. https://doi.org/10.1155/2022/9282484
  4. Wang, Y. et al. (2019) SIRT2: Controversy and multiple roles in disease and physiology. Ageing Research Review, 55(6):100961. Review. https://doi.org/10.1016/j.arr.2019.100961
  5. Eldridge, M. J. G. et al (2020) Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins. Nature Scientific Reports, 10:2034, 1-12. https://doi.org/10.1038/s41598-020-58397-6
  6. Piracha, Z. Z. et al (2020) An Alternatively Spliced Sirtuin 2 Isoform 5 Inhibits Hepatitis B Virus Replication from cccDNA by Repressing Epigenetic Modifications Made by Histone Lysine Methyltransferases. Journal of Virology, 94(16)  https://doi.org/10.1128/JVI.00926-20
Tagged under: Innate Immunity, neurodegenerative disease, SIRT2, Sirtuin 2

What you can read next

atpase activity assays for drug discovery
Using an ATPase Activity Assay for Drug Discovery
FP Assays
Fluorescence Polarization Assays for Drug Discovery
Greatwall: Cancer’s Great Defender?

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Preview of DNA Damage Repair Webinar

    [Webinar] Targeting DNA Damage Repair for Drug Discovery Using the Transcreener ADPR® Assay

    Interested in DNA damage repair pathways for dr...
  • Calculating MAPK14 Residence Time

    Transcreener® ADP2 Assay Delivers Precise Measurement of Functional MAPK14 Residence Time

    Researchers at the University of Tubingen use T...
  • DDX1 as a versatile RNA Helicase

    DDX1: A Versatile RNA Helicase

    DDX1 (Dead-Box Helicase 1) belongs to the DEAD-...
  • RAB2 Transports Membrane Bound Vesicles

    Investigating RAB2 as a Vesicle Transporter & Autophagy Initiator

    RAB2 is part of the RAB family of small GTPases...
  • PARP1 as a Hero vs Villain

    Is PARP1 a Hero or Villain?

    Not counting histones, PARP1 [Poly(ADP-ribose) ...

Archives

BellBrook Labs
1232 Fourier Drive, Suite 115
Madison, Wisconsin 53717 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2023 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP